首页> 外文期刊>Graefe's archive for clinical and experimental ophthalmology: Albrecht von Graefes Archiv fur klinische und experimentelle Opthalmologie >Visual outcomes and complications following posterior iris-claw aphakic intraocular lens implantation combined with penetrating keratoplasty
【24h】

Visual outcomes and complications following posterior iris-claw aphakic intraocular lens implantation combined with penetrating keratoplasty

机译:后虹膜爪无晶状体人工晶状体植入联合穿透性角膜移植术后的视觉结果和并发症

获取原文
获取原文并翻译 | 示例
           

摘要

Background: To evaluate the indication, visual outcome, and complication rate after implantation of a posterior iris-claw aphakic intraocular lens (IOL) during penetrating keratoplasty. Methods: This retrospective study comprised 23 eyes (23 patients) without adequate capsule support undergoing posterior iris-claw aphakic IOL implantation (Verisyse?/Artisan?) during penetrating keratoplasty between 2005 and 2010. Mean follow-up was 18 months (range from 12 to 37 months). Results: The IOLs were inserted during an IOL exchange in 17 eyes and as a secondary procedure in six aphakic eyes. Pseudophakic bullous keratopathy with corneal scar after anterior chamber intraocular lens (ACIOL) was the main indication for penetrating keratoplasty in 16 eyes (69.6 %). The final corrected distance visual acuity (CDVA) in logMAR (mean 1.0 ± 0.46) improved significantly (p < 0.05) compared to the preoperative CDVA (mean 1.8 ± 0.73). Twenty eyes (86.9 %) had a final visual acuity in logMAR better than the pre-operative CDVA. The mean postoperative IOP 16.3 mmHg ± 4.0 was not significantly (p > 0.05) higher compared to the preoperative IOP 15.6 mmHg ± 5.1. Complications included slight temporary pupil ovalization in three eyes (13.0 %) and iris-claw IOL sublocation in three eyes (13.0 %); all IOLs could be easily repositioned. Cystoid macular edema occured in one eye (4.3 %) 8 weeks after primary surgery. All grafts remained clear without any sign of graft rejection. Conclusions: Retropupillar iris-claw IOL during penetrating keratoplasty provides good visual outcomes with a favorable complication rate, and can be used for a wide range of indications in eyes without adequate capsule support.
机译:背景:为了评估穿透性角膜移植手术后虹膜爪无晶状体无晶体人工晶状体植入后的适应症,视觉效果和并发症发生率。方法:这项回顾性研究包括2005年至2010年在穿透性角膜移植术中没有虹膜爪无晶状体后眼人工晶状体后植入术(Verisyse?/ Artisan?)的23眼(23例患者),没有足够的囊膜支持。平均随访18个月(范围从12至37个月)。结果:将IOL插入IOL交换过程中的17只眼中,并作为第二过程插入了6张无晶状体眼中。前房人工晶状体(ACIOL)术后假晶状体大疱性角膜病变伴角膜瘢痕是16眼穿透性角膜移植术的主要指征(69.6%)。与术前CDVA(平均值1.8±0.73)相比,logMAR中的最终矫正远视力(CDVA)(平均值1.0±0.46)显着改善(p <0.05)。 20眼(86.9%)的logMAR最终视力优于术前CDVA。术后平均眼压为16.3 mmHg±4.0,与术前平均眼压15.6 mmHg±5.1相比,无显着性(p> 0.05)。并发症包括三只眼出现暂时性暂时性瞳孔椭圆化(13.0%)和三只眼虹膜爪IOL移位(13.0%);所有IOL都可以轻松地重新定位。初次手术8周后,一只眼(4.3%)发生了黄斑囊样水肿。所有移植物保持透明,没有任何排斥迹象。结论:穿透性角膜移植术后瞳孔后虹膜爪IOL可提供良好的视觉效果,并具有良好的并发症发生率,并且在没有足够胶囊支持的情况下可用于多种眼部适应症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号